APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Integrin Alpha 4

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Integrin Alpha 4 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174003670326 December 2025192 pages

Choose your research edition.

Industry ResearchIntegrin Alpha 4 Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Integrin Alpha 4 Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Integrin Alpha 4 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Integrin Alpha 4 Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Integrin Alpha 4 Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Integrin Alpha 4 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Integrin Alpha 4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Integrin Alpha 4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Integrin Alpha 4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Integrin Alpha 4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Integrin Alpha 4 include Takeda Pharmaceutical Co Ltd, Viriom Inc, Protagonist Therapeutics Inc, Morphic Therapeutic Inc, Immunwork Inc, EA Pharma Co Ltd, Daiichi Sankyo Co Ltd, BioMAS Ltd and Biogen Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Integrin Alpha 4 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Integrin Alpha 4 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Integrin Alpha 4 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Integrin Alpha 4 market size, projected growth trends, production technologies, key applications, and end-use industries.

Integrin Alpha 4 Segment by Company

Takeda Pharmaceutical Co Ltd

Viriom Inc

Protagonist Therapeutics Inc

Morphic Therapeutic Inc

Immunwork Inc

EA Pharma Co Ltd

Daiichi Sankyo Co Ltd

BioMAS Ltd

Biogen Inc

Antisense Therapeutics Ltd

Amgen Inc

Integrin Alpha 4 Segment by Type

ATL-1102

Carotegrast

ET-3764

TE-5232

Others

Integrin Alpha 4 Segment by Application

Acute Ischemic Stroke

Melanoma

Celiac Disease

Multiple Sclerosis

Epilepsy

Other

Integrin Alpha 4 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Integrin Alpha 4 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Integrin Alpha 4 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Integrin Alpha 4.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Integrin Alpha 4 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Integrin Alpha 4 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Integrin Alpha 4 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Integrin Alpha 4 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Integrin Alpha 4 Industry Trends Table 2. Integrin Alpha 4 Industry Drivers Table 3. Integrin Alpha 4 Industry Opportunities and Challenges Table 4. Integrin Alpha 4 Industry Restraints Table 5. Global Integrin Alpha 4 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Integrin Alpha 4 Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Integrin Alpha 4 Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Integrin Alpha 4 Sales Market Share by Manufacturers Table 9. Global Integrin Alpha 4 Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Integrin Alpha 4 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Integrin Alpha 4 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Integrin Alpha 4 Manufacturers, Product Type & Application Table 13. Global Integrin Alpha 4 Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Integrin Alpha 4 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of ATL-1102 Table 17. Major Manufacturers of Carotegrast Table 18. Major Manufacturers of ET-3764 Table 19. Major Manufacturers of TE-5232 Table 20. Major Manufacturers of Others Table 21. Global Integrin Alpha 4 Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 22. Global Integrin Alpha 4 Sales by Type (2021-2026) & (W Units) Table 23. Global Integrin Alpha 4 Sales by Type (2027-2032) & (W Units) Table 24. Global Integrin Alpha 4 Sales Market Share by Type (2021-2026) Table 25. Global Integrin Alpha 4 Sales Market Share by Type (2027-2032) Table 26. Global Integrin Alpha 4 Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 27. Global Integrin Alpha 4 Revenue by Type (2021-2026) & (W Units) Table 28. Global Integrin Alpha 4 Revenue by Type (2027-2032) & (W Units) Table 29. Global Integrin Alpha 4 Revenue Market Share by Type (2021-2026) Table 30. Global Integrin Alpha 4 Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Acute Ischemic Stroke Table 32. Major Manufacturers of Melanoma Table 33. Major Manufacturers of Celiac Disease Table 34. Major Manufacturers of Multiple Sclerosis Table 35. Major Manufacturers of Epilepsy Table 36. Major Manufacturers of Other Table 37. Global Integrin Alpha 4 Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 38. Global Integrin Alpha 4 Sales by Application (2021-2026) & (W Units) Table 39. Global Integrin Alpha 4 Sales by Application (2027-2032) & (W Units) Table 40. Global Integrin Alpha 4 Sales Market Share by Application (2021-2026) Table 41. Global Integrin Alpha 4 Sales Market Share by Application (2027-2032) Table 42. Global Integrin Alpha 4 Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 43. Global Integrin Alpha 4 Revenue by Application (2021-2026) & (W Units) Table 44. Global Integrin Alpha 4 Revenue by Application (2027-2032) & (W Units) Table 45. Global Integrin Alpha 4 Revenue Market Share by Application (2021-2026) Table 46. Global Integrin Alpha 4 Revenue Market Share by Application (2027-2032) Table 47. Global Integrin Alpha 4 Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 48. Global Integrin Alpha 4 Sales by Region (2021-2026) & (W Units) Table 49. Global Integrin Alpha 4 Sales Market Share by Region (2021-2026) Table 50. Global Integrin Alpha 4 Sales Forecasted by Region (2027-2032) & (W Units) Table 51. Global Integrin Alpha 4 Sales Forecasted Market Share by Region (2027-2032) Table 52. North America Integrin Alpha 4 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 53. North America Integrin Alpha 4 Sales by Country (2021-2026) & (W Units) Table 54. North America Integrin Alpha 4 Sales by Country (2027-2032) & (W Units) Table 55. Europe Integrin Alpha 4 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. Europe Integrin Alpha 4 Sales by Country (2021-2026) & (W Units) Table 57. Europe Integrin Alpha 4 Sales by Country (2027-2032) & (W Units) Table 58. Asia Pacific Integrin Alpha 4 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 59. Asia Pacific Integrin Alpha 4 Sales by Country (2021-2026) & (W Units) Table 60. Asia Pacific Integrin Alpha 4 Sales by Country (2027-2032) & (W Units) Table 61. South America, Middle East and Africa Integrin Alpha 4 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 62. South America, Middle East and Africa Integrin Alpha 4 Sales by Country (2021-2026) & (W Units) Table 63. South America, Middle East and Africa Integrin Alpha 4 Sales by Country (2027-2032) & (W Units) Table 64. Global Integrin Alpha 4 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global Integrin Alpha 4 Revenue by Region (2021-2026) & (US$ Million) Table 66. Global Integrin Alpha 4 Revenue by Region (2027-2032) & (US$ Million) Table 67. Global Integrin Alpha 4 Revenue Market Share by Region (2021-2026) Table 68. Global Integrin Alpha 4 Revenue Market Share by Region (2027-2032) Table 69. Takeda Pharmaceutical Co Ltd Company Information Table 70. Takeda Pharmaceutical Co Ltd Business Overview Table 71. Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Product Portfolio Table 73. Takeda Pharmaceutical Co Ltd Recent Development Table 74. Viriom Inc Company Information Table 75. Viriom Inc Business Overview Table 76. Viriom Inc Integrin Alpha 4 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Viriom Inc Integrin Alpha 4 Product Portfolio Table 78. Viriom Inc Recent Development Table 79. Protagonist Therapeutics Inc Company Information Table 80. Protagonist Therapeutics Inc Business Overview Table 81. Protagonist Therapeutics Inc Integrin Alpha 4 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Protagonist Therapeutics Inc Integrin Alpha 4 Product Portfolio Table 83. Protagonist Therapeutics Inc Recent Development Table 84. Morphic Therapeutic Inc Company Information Table 85. Morphic Therapeutic Inc Business Overview Table 86. Morphic Therapeutic Inc Integrin Alpha 4 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Morphic Therapeutic Inc Integrin Alpha 4 Product Portfolio Table 88. Morphic Therapeutic Inc Recent Development Table 89. Immunwork Inc Company Information Table 90. Immunwork Inc Business Overview Table 91. Immunwork Inc Integrin Alpha 4 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Immunwork Inc Integrin Alpha 4 Product Portfolio Table 93. Immunwork Inc Recent Development Table 94. EA Pharma Co Ltd Company Information Table 95. EA Pharma Co Ltd Business Overview Table 96. EA Pharma Co Ltd Integrin Alpha 4 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. EA Pharma Co Ltd Integrin Alpha 4 Product Portfolio Table 98. EA Pharma Co Ltd Recent Development Table 99. Daiichi Sankyo Co Ltd Company Information Table 100. Daiichi Sankyo Co Ltd Business Overview Table 101. Daiichi Sankyo Co Ltd Integrin Alpha 4 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Daiichi Sankyo Co Ltd Integrin Alpha 4 Product Portfolio Table 103. Daiichi Sankyo Co Ltd Recent Development Table 104. BioMAS Ltd Company Information Table 105. BioMAS Ltd Business Overview Table 106. BioMAS Ltd Integrin Alpha 4 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. BioMAS Ltd Integrin Alpha 4 Product Portfolio Table 108. BioMAS Ltd Recent Development Table 109. Biogen Inc Company Information Table 110. Biogen Inc Business Overview Table 111. Biogen Inc Integrin Alpha 4 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Biogen Inc Integrin Alpha 4 Product Portfolio Table 113. Biogen Inc Recent Development Table 114. Antisense Therapeutics Ltd Company Information Table 115. Antisense Therapeutics Ltd Business Overview Table 116. Antisense Therapeutics Ltd Integrin Alpha 4 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Antisense Therapeutics Ltd Integrin Alpha 4 Product Portfolio Table 118. Antisense Therapeutics Ltd Recent Development Table 119. Amgen Inc Company Information Table 120. Amgen Inc Business Overview Table 121. Amgen Inc Integrin Alpha 4 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Amgen Inc Integrin Alpha 4 Product Portfolio Table 123. Amgen Inc Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Integrin Alpha 4 Distributors List Table 127. Integrin Alpha 4 Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Integrin Alpha 4 Product Image Figure 2. Global Integrin Alpha 4 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Integrin Alpha 4 Market Size (2021-2032) & (US$ Million) Figure 4. Global Integrin Alpha 4 Sales (2021-2032) & (W Units) Figure 5. Global Integrin Alpha 4 Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Integrin Alpha 4 Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. ATL-1102 Image Figure 9. Carotegrast Image Figure 10. ET-3764 Image Figure 11. TE-5232 Image Figure 12. Others Image Figure 13. Global Integrin Alpha 4 Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Integrin Alpha 4 Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Integrin Alpha 4 Sales Market Share by Type (2021-2032) Figure 16. Global Integrin Alpha 4 Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 17. Global Integrin Alpha 4 Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Integrin Alpha 4 Revenue Market Share by Type (2021-2032) Figure 19. Acute Ischemic Stroke Image Figure 20. Melanoma Image Figure 21. Celiac Disease Image Figure 22. Multiple Sclerosis Image Figure 23. Epilepsy Image Figure 24. Other Image Figure 25. Global Integrin Alpha 4 Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 26. Global Integrin Alpha 4 Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global Integrin Alpha 4 Sales Market Share by Application (2021-2032) Figure 28. Global Integrin Alpha 4 Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 29. Global Integrin Alpha 4 Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global Integrin Alpha 4 Revenue Market Share by Application (2021-2032) Figure 31. North America Integrin Alpha 4 Sales and Growth Rate (2021-2032) & (W Units) Figure 32. North America Integrin Alpha 4 Sales Market Share by Country (2021-2032) Figure 33. U.S. Integrin Alpha 4 Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Canada Integrin Alpha 4 Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Mexico Integrin Alpha 4 Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Europe Integrin Alpha 4 Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Europe Integrin Alpha 4 Sales Market Share by Country (2021-2032) Figure 38. Germany Integrin Alpha 4 Sales and Growth Rate (2021-2032) & (W Units) Figure 39. France Integrin Alpha 4 Sales and Growth Rate (2021-2032) & (W Units) Figure 40. U.K. Integrin Alpha 4 Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Italy Integrin Alpha 4 Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Netherlands Integrin Alpha 4 Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Asia Pacific Integrin Alpha 4 Sales and Growth Rate (2021-2032) & (W Units) Figure 44. Asia Pacific Integrin Alpha 4 Sales Market Share by Country (2021-2032) Figure 45. China Integrin Alpha 4 Sales and Growth Rate (2021-2032) & (W Units) Figure 46. Japan Integrin Alpha 4 Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South Korea Integrin Alpha 4 Sales and Growth Rate (2021-2032) & (W Units) Figure 48. Southeast Asia Integrin Alpha 4 Sales and Growth Rate (2021-2032) & (W Units) Figure 49. India Integrin Alpha 4 Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Australia Integrin Alpha 4 Sales and Growth Rate (2021-2032) & (W Units) Figure 51. South America, Middle East and Africa Integrin Alpha 4 Sales and Growth Rate (2021-2032) & (W Units) Figure 52. South America, Middle East and Africa Integrin Alpha 4 Sales Market Share by Country (2021-2032) Figure 53. Brazil Integrin Alpha 4 Sales and Growth Rate (2021-2032) & (W Units) Figure 54. South Africa Integrin Alpha 4 Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Saudi Arabia Integrin Alpha 4 Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Turkey Integrin Alpha 4 Sales and Growth Rate (2021-2032) & (W Units) Figure 57. Argentina Integrin Alpha 4 Sales and Growth Rate (2021-2032) & (W Units) Figure 58. UAE Integrin Alpha 4 Sales and Growth Rate (2021-2032) & (W Units) Figure 59. Egypt Integrin Alpha 4 Sales and Growth Rate (2021-2032) & (W Units) Figure 60. Chile Integrin Alpha 4 Sales and Growth Rate (2021-2032) & (W Units) Figure 61. Global Integrin Alpha 4 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global Integrin Alpha 4 Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Figure 64. North America Integrin Alpha 4 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Figure 66. Europe Integrin Alpha 4 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific Integrin Alpha 4 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa Integrin Alpha 4 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. Integrin Alpha 4 Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Integrin Alpha 4 Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • ATL-1102
  • Carotegrast
  • ET-3764
  • TE-5232
  • Others
Applications
  • Acute Ischemic Stroke
  • Melanoma
  • Celiac Disease
  • Multiple Sclerosis
  • Epilepsy
  • Other
Companies covered
  • Takeda Pharmaceutical Co Ltd
  • Viriom Inc
  • Protagonist Therapeutics Inc
  • Morphic Therapeutic Inc
  • Immunwork Inc
  • EA Pharma Co Ltd
  • Daiichi Sankyo Co Ltd
  • BioMAS Ltd
  • Biogen Inc
  • Antisense Therapeutics Ltd
  • Amgen Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Integrin Alpha 4 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Integrin Alpha 4 Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Integrin Alpha 4 Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Integrin Alpha 4 Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Integrin Alpha 4 Market Dynamics
  1. 2.1 Integrin Alpha 4 Industry Trends
  2. 2.2 Integrin Alpha 4 Industry Drivers
  3. 2.3 Integrin Alpha 4 Industry Opportunities and Challenges
  4. 2.4 Integrin Alpha 4 Industry Restraints
3 Integrin Alpha 4 Market by Manufacturers
  1. 3.1 Global Integrin Alpha 4 Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Integrin Alpha 4 Sales by Manufacturers (2021-2026)
  3. 3.3 Global Integrin Alpha 4 Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Integrin Alpha 4 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Integrin Alpha 4 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Integrin Alpha 4 Manufacturers, Product Type & Application
  7. 3.7 Global Integrin Alpha 4 Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Integrin Alpha 4 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Integrin Alpha 4 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Integrin Alpha 4 Tier 1, Tier 2, and Tier 3
4 Integrin Alpha 4 Market by Type
  1. 4.1 Integrin Alpha 4 Type Introduction
  2. 4.1.1 ATL-1102
  3. 4.1.2 Carotegrast
  4. 4.1.3 ET-3764
  5. 4.1.4 TE-5232
  6. 4.1.5 Others
  7. 4.2 Global Integrin Alpha 4 Sales by Type
  8. 4.2.1 Global Integrin Alpha 4 Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Integrin Alpha 4 Sales by Type (2021-2032)
  10. 4.2.3 Global Integrin Alpha 4 Sales Market Share by Type (2021-2032)
  11. 4.3 Global Integrin Alpha 4 Revenue by Type
  12. 4.3.1 Global Integrin Alpha 4 Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Integrin Alpha 4 Revenue by Type (2021-2032)
  14. 4.3.3 Global Integrin Alpha 4 Revenue Market Share by Type (2021-2032)
5 Integrin Alpha 4 Market by Application
  1. 5.1 Integrin Alpha 4 Application Introduction
  2. 5.1.1 Acute Ischemic Stroke
  3. 5.1.2 Melanoma
  4. 5.1.3 Celiac Disease
  5. 5.1.4 Multiple Sclerosis
  6. 5.1.5 Epilepsy
  7. 5.1.6 Other
  8. 5.2 Global Integrin Alpha 4 Sales by Application
  9. 5.2.1 Global Integrin Alpha 4 Sales by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Integrin Alpha 4 Sales by Application (2021-2032)
  11. 5.2.3 Global Integrin Alpha 4 Sales Market Share by Application (2021-2032)
  12. 5.3 Global Integrin Alpha 4 Revenue by Application
  13. 5.3.1 Global Integrin Alpha 4 Revenue by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Integrin Alpha 4 Revenue by Application (2021-2032)
  15. 5.3.3 Global Integrin Alpha 4 Revenue Market Share by Application (2021-2032)
6 Global Integrin Alpha 4 Sales by Region
  1. 6.1 Global Integrin Alpha 4 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Integrin Alpha 4 Sales by Region (2021-2032)
  3. 6.2.1 Global Integrin Alpha 4 Sales by Region (2021-2026)
  4. 6.2.2 Global Integrin Alpha 4 Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Integrin Alpha 4 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Integrin Alpha 4 Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Integrin Alpha 4 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Integrin Alpha 4 Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Integrin Alpha 4 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Integrin Alpha 4 Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Integrin Alpha 4 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Integrin Alpha 4 Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Integrin Alpha 4 Revenue by Region
  1. 7.1 Global Integrin Alpha 4 Revenue by Region
  2. 7.1.1 Global Integrin Alpha 4 Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Integrin Alpha 4 Revenue by Region (2021-2026)
  4. 7.1.3 Global Integrin Alpha 4 Revenue by Region (2027-2032)
  5. 7.1.4 Global Integrin Alpha 4 Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Integrin Alpha 4 Revenue (2021-2032)
  8. 7.2.2 North America Integrin Alpha 4 Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Integrin Alpha 4 Revenue (2021-2032)
  11. 7.3.2 Europe Integrin Alpha 4 Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Integrin Alpha 4 Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Integrin Alpha 4 Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Integrin Alpha 4 Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Integrin Alpha 4 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda Pharmaceutical Co Ltd
  2. 8.1.1 Takeda Pharmaceutical Co Ltd Company Information
  3. 8.1.2 Takeda Pharmaceutical Co Ltd Business Overview
  4. 8.1.3 Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Product Portfolio
  6. 8.1.5 Takeda Pharmaceutical Co Ltd Recent Developments
  7. 8.2 Viriom Inc
  8. 8.2.1 Viriom Inc Company Information
  9. 8.2.2 Viriom Inc Business Overview
  10. 8.2.3 Viriom Inc Integrin Alpha 4 Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Viriom Inc Integrin Alpha 4 Product Portfolio
  12. 8.2.5 Viriom Inc Recent Developments
  13. 8.3 Protagonist Therapeutics Inc
  14. 8.3.1 Protagonist Therapeutics Inc Company Information
  15. 8.3.2 Protagonist Therapeutics Inc Business Overview
  16. 8.3.3 Protagonist Therapeutics Inc Integrin Alpha 4 Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Protagonist Therapeutics Inc Integrin Alpha 4 Product Portfolio
  18. 8.3.5 Protagonist Therapeutics Inc Recent Developments
  19. 8.4 Morphic Therapeutic Inc
  20. 8.4.1 Morphic Therapeutic Inc Company Information
  21. 8.4.2 Morphic Therapeutic Inc Business Overview
  22. 8.4.3 Morphic Therapeutic Inc Integrin Alpha 4 Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Morphic Therapeutic Inc Integrin Alpha 4 Product Portfolio
  24. 8.4.5 Morphic Therapeutic Inc Recent Developments
  25. 8.5 Immunwork Inc
  26. 8.5.1 Immunwork Inc Company Information
  27. 8.5.2 Immunwork Inc Business Overview
  28. 8.5.3 Immunwork Inc Integrin Alpha 4 Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Immunwork Inc Integrin Alpha 4 Product Portfolio
  30. 8.5.5 Immunwork Inc Recent Developments
  31. 8.6 EA Pharma Co Ltd
  32. 8.6.1 EA Pharma Co Ltd Company Information
  33. 8.6.2 EA Pharma Co Ltd Business Overview
  34. 8.6.3 EA Pharma Co Ltd Integrin Alpha 4 Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 EA Pharma Co Ltd Integrin Alpha 4 Product Portfolio
  36. 8.6.5 EA Pharma Co Ltd Recent Developments
  37. 8.7 Daiichi Sankyo Co Ltd
  38. 8.7.1 Daiichi Sankyo Co Ltd Company Information
  39. 8.7.2 Daiichi Sankyo Co Ltd Business Overview
  40. 8.7.3 Daiichi Sankyo Co Ltd Integrin Alpha 4 Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Daiichi Sankyo Co Ltd Integrin Alpha 4 Product Portfolio
  42. 8.7.5 Daiichi Sankyo Co Ltd Recent Developments
  43. 8.8 BioMAS Ltd
  44. 8.8.1 BioMAS Ltd Company Information
  45. 8.8.2 BioMAS Ltd Business Overview
  46. 8.8.3 BioMAS Ltd Integrin Alpha 4 Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 BioMAS Ltd Integrin Alpha 4 Product Portfolio
  48. 8.8.5 BioMAS Ltd Recent Developments
  49. 8.9 Biogen Inc
  50. 8.9.1 Biogen Inc Company Information
  51. 8.9.2 Biogen Inc Business Overview
  52. 8.9.3 Biogen Inc Integrin Alpha 4 Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Biogen Inc Integrin Alpha 4 Product Portfolio
  54. 8.9.5 Biogen Inc Recent Developments
  55. 8.10 Antisense Therapeutics Ltd
  56. 8.10.1 Antisense Therapeutics Ltd Company Information
  57. 8.10.2 Antisense Therapeutics Ltd Business Overview
  58. 8.10.3 Antisense Therapeutics Ltd Integrin Alpha 4 Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Antisense Therapeutics Ltd Integrin Alpha 4 Product Portfolio
  60. 8.10.5 Antisense Therapeutics Ltd Recent Developments
  61. 8.11 Amgen Inc
  62. 8.11.1 Amgen Inc Company Information
  63. 8.11.2 Amgen Inc Business Overview
  64. 8.11.3 Amgen Inc Integrin Alpha 4 Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Amgen Inc Integrin Alpha 4 Product Portfolio
  66. 8.11.5 Amgen Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Integrin Alpha 4 Value Chain Analysis
  2. 9.1.1 Integrin Alpha 4 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Integrin Alpha 4 Production Mode & Process
  6. 9.2 Integrin Alpha 4 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Integrin Alpha 4 Distributors
  9. 9.2.3 Integrin Alpha 4 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst